University of Vermont Cancer Center members Jane Lian, Ph.D., and Janet Stein, Ph.D., have been elected Fellows of the American Association for the Advancement of Science (AAAS) in recognition of their contributions to innovation, education, and scientific leadership. The announcement of the AAAS 2016 Fellows was featured in the November 25, 2016 issue of Science.

Among the side effects experienced by cancer patients undergoing chemotherapy is a higher risk of blood clots, but determining which patients are most likely to get them is a challenge for physicians.

Antioxidant therapies may hold promise for the nearly 25 million Americans suffering from asthma, and additional 140,000 people diagnosed with pulmonary fibrosis, but to date, determining exactly how to modify them into a feasible treatment has proved challenging.

“If you are ever going to be involved in cancer research, this is the moment,” Vice President Joe Biden told a packed Davis Center ballroom at the University of Vermont Oct. 21. “This is the inflection point.”

The University of Vermont Cancer Center is hosting two events as part of the Waldron Lecture series on Tuesday, September 13 and Wednesday September 14, 2016 featuring Maureen Connor, R.N., M.P.H., an oncology nurse and leader in the field of patient- and family-centered care.

In May, Vermont became the 28th state to adopt legislation mandating reporting of breast density information to patients. New University of Vermont (UVM) research - published July 18, 2016 in the Annals of Internal Medicine - shows that density assessment, as currently practiced, is subjective and highly variable across radiologists and warns of the implications of relying on the subjective measurement for clinical decision-making for breast cancer screening.

Attitudes and tobacco use before and after the launch of the University of Vermont's tobacco-free campus policy and barriers to providing opioid dependence treatment in primary care offices were topics for two of 16 University of Vermont College of Medicine Public Health Projects conducted by medical students in the Class of 2018 during the fall 2015 semester.

He’s not a personal trainer, but University of Vermont Associate Professor of Medicine Michael Toth, Ph.D., has an idea for counteracting the muscle loss that commonly occurs in cancer patients. What causes this loss in muscle loss – or atrophy – with cancer and its treatment is still not known, but Toth believes that the reduction in physical activity during cancer treatment may be an important factor.

The University of Vermont Cancer Center’s annual Clinical and Translational Research Symposium took place on Friday, April 29, 2016 in the UVM Medical Center’s Davis Auditorium and provided a day of learning and scientific collaboration on the topic of “Thrombosis, Hemostasis, and Cancer.” Experts from across North America joined UVM Cancer Center members and colleagues to discuss the science of bleeding, blood clots, and related complications in cancer care.

The University of Vermont Cancer Center presented two events at the College of Medicine on June 23 and June 24 to highlight important research and information relating to men’s health and cancer.

While better technology and screening practices have led to the detection of more breast cancers in women—many of which fall into a broad category of early-stage cancer, including ductal carcinoma in situ or DCIS—researchers still do not understand why some of these early cancers remain idle, while others progress. With the support of a new, $3.7 million federal grant from the National Cancer Institute (NCI), an interdisciplinary team of researchers at the University of Vermont (UVM) Cancer Center will be looking to answer this question.

Full story >>